Immune Response, Safety, and Survival and Quality of Life Outcomes for Advanced Colorectal Cancer Patients Treated with Dendritic Cell Vaccine and Cytokine-Induced Killer Cell Therapy

Purpose. To determine the immune response after dendritic cell (DC) vaccine and cytokine-induced killer cells (CIK) therapy and assess its associated toxicity, survival benefit, and changes in the quality of life (QOL) of advanced colorectal cancer (CRC) patients. Methods. We recruited 100 patients...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Zhu, Hui, Yang, Xuejing, Li, Jiali, Ren, Yanjie, Zhang, Tianyu, Zhang, Chunze, Zhang, Jintai, Li, Jing, Pang, Yan
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2014
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4124766/
https://ncbi.nlm.nih.gov/pubmed/25136601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/603871
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky